About
A theoretical physicist-turned biomedical engineer. One of two of my current research interests involves personalized patient therapeutics with small-data and mechanism-agnostic phenotypic medicine platforms. I am currently leading the computational team in a phase 2/3 trial on CURATE.AI-guided therapy for multiple myeloma, a type of hematological malignancy (NCT03759093), in collaboration with Prof. Chng Wee Joo and Dr. Sanjay de Mel at the National University Cancer Institute, Singapore (NCIS). Additionally, under the PRECISE CURATE.AI pilot clinical trial (NCT04522284), I am leading the computational team for a prospective CURATE.AI-guided targeted therapy cohort for Waldenström macroglobulinemia, another type of hematological malignancy. Additionally, I am investigating unconventional solutions for medical problems at the intersection point of Physics, Engineering, and Medicine. As a part of the research effort to personalize radiotherapy, I have proposed a perspective piece in the British Journal of Cancer (IF: 8.1) on a potential new workflow for personalization of radiotherapy with CURATE, and it was accepted based on clinicians’ review. Currently, I am exploring the potential of CURATE-guided radiotherapy through in-depth physical and biological studies on novel response markers, as well as in silico modelling work, in collaboration with the NUS Mechanobiology Institute, the National Cancer Centre Singapore (NCCS), and NCIS.